Melatonin in the management of insomnia

Date: 2 June 2021

The down scheduling of prolonged-release melatonin to Pharmacist-Only for the management of primary insomnia in people aged over 55 years old came into effect on 1 June 2021.

From this time, pharmacists have a greater role to play in providing information and support to patients with insomnia, including the supply of melatonin in line with the TGA decision.

Guild Learning and Development has partnered with Aspen Australia in the development of a new online course titled ‘Melatonin for the management of insomnia’ to assist pharmacists navigate this new area.

The course educates pharmacists on the science of sleep, the role of melatonin, and when to recommend melatonin to patients.

It focuses on Circadin® (prolonged release melatonin), and increasing pharmacist confidence when speaking with patients about sleep and the counselling points for melatonin use.

To enrol in this course please visit guilded.guild.org.au

Please contact Guild Learning and Development on 1800 049 056 or email learninganddevelopment@guild.org.au for more information.

Guild Learning and Development thanks Aspen Australiafor its financial support and subject matter expertise in developing this module.

This activity has been accredited for 1 hour of Group 1 CPD (or 1 CPD credit), suitable for inclusion in an individual pharmacist’s CPD plan, which can be converted to 1 hour of Group 2 CPD (or 2 CPD credits) upon successful completion of relevant assessment activities.

Contact: Peter Waterman
Phone: 0419 260 827

Page last updated on: 16 February 2022